New report published by Global Info Research which offers insights on the global Allergy Immunotherapy market.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system’s response.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-allergy-immunotherapy-market_p84655.html
Global Allergy Immunotherapy Market: Forecast by Type / Application / Region
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
The major players in global Allergy Immunotherapy market include: ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, WOLW Pharma and Holister Stier, Leti.
On the basis on the types covers: Subcutaneous Immunotherapy and Sublingual Immunotherapy.
On the basis on the end users/applications covers: Allergic Rhinitis, Allergic Asthma and Other.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In the last several years, global market of Allergy Immunotherapy developed rapidly, with an average growth rate of 10.7%. In 2017, global revenue of Allergy Immunotherapy is about 1100 million USD. Today, allergic diseases affect the lives of more than one billion people worldwide. With an epidemic rise over the last 60 years, prevalence is expected to reach up to four billion people by 2050. Globally, the market is characterized by growing prevalence, unmet patient needs and opportunities for tailored treatment.
Allergy Immunotherapy are application in Allergic Rhinitis, Allergic Asthma and Other. The most of Allergy Immunotherapy is used in Allergic Rhinitis, and the market share of that is about 45.3 % in 2017.
Europe is the largest consumption place, with a consumption market share nearly 68.5% in 2017, Allergy is the most common chronic disease in Europe. Up to 20% of patients with allergies struggle daily with the fear of a possible asthma attack, anaphylactic shock, or even death from an allergic reaction. Following Europe, North America is the second largest consumption place with the consumption market share of 19.2% in 2017. Allergy Immunotherapy market in Asia Pacific region is expected to exhibit the highest growth rate due to high incidence of allergy people in the developing Asian countries like China & India.
Market competition is intense. ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, etc. are the leaders of the industry with the market share is about 76.6% in 2017.
Ask for Discount on Research Report and Request Sample Copy of Report@
https://www.globalinforesearch.com/global-allergy-immunotherapy-market_p84655.html
About Us:
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Related Information:
United States Allergy Immunotherapy Market 2018 Forecast to 2023
Europe Allergy Immunotherapy Market 2018 Forecast to 2023
North America Allergy Immunotherapy Market 2018 Forecast to 2023
Asia-Pacific Allergy Immunotherapy Market 2018 Forecast to 2023
China Allergy Immunotherapy Market 2018 Forecast to 2023
EMEA Allergy Immunotherapy Market 2018 Forecast to 2023
Global Allergy Immunotherapy Market 2018 Forecast to 2023
Contact US :
JOE
Sales Director (Global Info Research)
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
Website: http://www.globalinforesearch.com
